PI3K-mTOR in Cancer and Cancer Therapy
In the post human-genome project era, cancer specific genomic maps are redesigning tumor taxonomy by evolving from histopathology to molecular pathology. The success of a cancer drug today is fundamentally based on the success in identifying target genes that control beneficial pathways. The overwhe...
Corporate Author: | SpringerLink (Online service) |
---|---|
Other Authors: | Dey, Nandini (Editor), De, Pradip (Editor), Leyland-Jones, Brian (Editor) |
Format: | Electronic eBook |
Language: | English |
Published: |
Cham :
Springer International Publishing : Imprint: Humana Press,
2016.
|
Series: | Cancer Drug Discovery and Development,
|
Subjects: | |
Online Access: | Full Text via HEAL-Link |
Similar Items
-
Resistance to Photodynamic Therapy in Cancer
Published: (2015) -
PARP Inhibitors for Cancer Therapy
Published: (2015) -
Nitric Oxide and Cancer: Pathogenesis and Therapy
Published: (2015) -
Resistance to Targeted ABC Transporters in Cancer
Published: (2015) -
Resistance to Aromatase Inhibitors in Breast Cancer
Published: (2015)